Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-COAP Trial in Older Adults With Chronic Pain
NCT06837857Phase 2Recruiting
- Sponsor
- Mayo Clinic
- Start
- Apr 2025
- Primary completion
- Jul 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxycodone in chronic pain (2 arms), sponsored by Mayo Clinic. Primary endpoint: White matter fractional anisotropy of corpus callosum at 12 months. Started Apr 2025; status: recruiting.
02
Drugs
oxycodone
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT06837857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06837857.